|
|
Substance Name: Olanzapine [USAN:USP:INN:BAN]
RN: 132539-06-1
UNII: N7U69T4SZR
InChIKey: KVWDHTXUZHCGIO-UHFFFAOYSA-N
Note
- A benzothiazepine.
Molecular Formula
- C17-H20-N4-S
Molecular Weight
- 312.439
Classification Codes
- Antiemetics
- Antipsychotic
- Antipsychotic Agents
- Autonomic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Gastrointestinal Agents
- Membrane Transport Modulators
- Neurotransmitter Agents
- Neurotransmitter Uptake Inhibitors
- Peripheral Nervous System Agents
- Psychotropic Drugs
- Serotonin Agents
- Serotonin Uptake Inhibitors
- Tranquilizing Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Olanzapine
- Olanzapine [USAN:USP:INN:BAN]
MeSH Heading
- Olanzapine
Synonyms
- 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
- HSDB 8155
- LY 170053
- LY-170053
- LY170053
- Olansek
- Olanzapine
- Olanzapine Teva
- Olanzapine Mylan
- Olanzapine Neopharma
- UNII-N7U69T4SZR
- Zalasta
- Zypadhera
- Zyprexa
- Zyprexa Intramuscular
- Zyprexa Velotab
- Zyprexa Zydis
Systematic Name
- 10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-
Mixture Name
- Symbyax
Registry Numbers
CAS Registry Number
- 132539-06-1
FDA UNII
- N7U69T4SZR
System Generated Number
- 0132539061
Structure Descriptors
InChI
InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3InChIKey
KVWDHTXUZHCGIO-UHFFFAOYSA-NSmiles
CN1CCN(CC1)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
human | TDLo | oral | 16560ug/kg/12 (16.56mg/kg) | Journal of Clinical Psychiatry. Vol. 60, Pg. 767, 1999. | |
human | TDLo | oral | 16560ug/kg/12 (16.56mg/kg) | BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)" | Journal of Clinical Psychiatry. Vol. 60, Pg. 767, 1999. |
human | TDLo | oral | 43mg/kg/30W-I (43mg/kg) | Journal of Clinical Pyschopharmacology. Vol. 19, Pg. 273, 1999. | |
man | LDLo | oral | 7067ug/kg (7.067mg/kg) | LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA GASTROINTESTINAL: NAUSEA OR VOMITING LIVER: "HEPATITIS, FIBROUS (CIRRHOSIS, POST-NECROTIC SCARRING)" | Journal of Forensic Sciences. Vol. 41, Pg. 1252, 1998. |
man | TDLo | oral | 2570ug/kg/12D (2.57mg/kg) | AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC | Journal of Clinical Pyschopharmacology. Vol. 19, Pg. 192, 1999. |
women | LDLo | oral | 30mg/kg/22W-I (30mg/kg) | VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Annals of Pharmacotherpy. Vol. 33, Pg. 787, 1999. |
women | TDLo | oral | 400ug/kg (0.4mg/kg) | American Journal of Psychiatry. Vol. 156, Pg. 1835, 1999. | |
women | TDLo | oral | 400ug/kg (0.4mg/kg) | VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION BEHAVIORAL: REGIDITY | American Journal of Psychiatry. Vol. 156, Pg. 1835, 1999. |
women | TDLo | oral | 12mg/kg (12mg/kg) | BEHAVIORAL: COMA CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE | Annals of Emergency Medicine. Vol. 32, Pg. 275, 1998. |
women | TDLo | oral | 12mg/kg/60D-I (12mg/kg) | BEHAVIORAL: TOXIC PSYCHOSIS | Annals of Internal Medicine. Vol. 131, Pg. 72, 1999. |